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Abstract 
There is enormous interest in the design and development of efficient chiral ligands for asymmetric 
catalysis, as a result, this field has become one of the most popular areas of research in organic 
chemistry.  This project involved the investigation of the novel chiral pentacyclo-undecane (PCU) 
diol 54a, PCU bisimine 87 and PCU bis(oxazoline) 100 type ligands.  The PCU diol ligand was 
synthesized, but proved to be difficult to obtain enantiomerically pure which hindered further 
investigation into this type of ligand.  The PCU bisimine ligand 87 was synthesized.  However due 
to its instability it was not further pursued.  Synthesis of the PCU bis(oxazoline) ligand 100 was 
successful.  This ligand was complexed to various metal salts and its efficiency as a chiral Lewis 
acid catalyst was evaluated on the asymmetric Diels-Alder reaction between 3-acryloyloxazolidin-
2-one 52 and cyclopentadiene 33.  The anhydrous magnesium perchlorate ligand complex emerged 
as the best catalyst providing the endo-cycloadduct product 53 in 81 % enantiomeric excess at -40 
oC.  Optimizations of the possible conformations of the magnesium complex of ligand 100 with the 
substrate 52 were performed using Density Functional Theory (DFT) calculations.  The more 
energetically favoured complex conformation was established.  The Re-face of the dienophile which 
was less hindered produced the product consistent with the experimentally observed product 16.  
Based on the calculated bond lengths from the computational model binding of the ether oxygen on 
the PCU moiety to magnesium was observed.  All the novel compounds were fully characterized 
using NMR, IR and mass spectroscopy as the main tools. 
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Chapter 1 
1.1  Origin and Importance of Chirality 
In 1848 Louis Pasteur was the first scientist to recognize that the optical activity of molecules is 
related to what we now refer to as chirality.1,2  He stated that similar molecules which rotate 
plane-polarised light through equal angles but in opposite directions must be related to each other 
as an object and its non-superimposable mirror image.  Pasteur came to this remarkable 
realization while working with crystals of sodium ammonium tartrate 1.2  He observed that the 
crystals were not identical, some of the crystals were ‘right-handed’ and some of them ‘left-
handed’.  Pasteur was able to separate these two enantiomorphous crystal forms with the use of a 
magnifying glass and a pair of tweezers.  He then found that plane-polarised light was reflected 
clockwise and anti-clockwise by solutions of the right-handed and left-handed crystals 
respectively.  This phenomenon was attributed to a property possessed by chiral molecules and 
the two forms of the optically active tartaric acid were related to each other as three-dimensional 










Enantiomers have identical chemical and physical properties3 hence they exhibit similar 
physiochemical properties such as melting points, solubility, chromatographic retention time, 
infrared4 (IR) and nuclear magnetic resonance (NMR) spectra.  However, enantiomers differ in 
the way they rotate plane-polarised light as stated above and when interacting with another chiral 
molecule.3,5  The majority of the vital building blocks which make up biological macromolecules 
(e.g. DNA, RNA, sugars and proteins) exist predominantly in one enantiomeric form.  As a result, 
when a biologically active chiral compound such as a drug interacts with a chiral receptor site in 
biological systems the two enantiomers of the drug will interact differently and may lead to 
different biochemical effects.3,5  In relation to biological activity their tastes, smells, toxicity, and 
other properties of enantiomers often differ vastly.1  There are a variety of examples of the 
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different activities of enantiomers.1-3,5  One of the most cited examples of this behavior was the 
fatal drug thalidomide which was used in the 1960’s.  Both enantiomers of the drug had the same 
sedative effect but only the (S)-(-)-enantiomer 2 caused death and deformities in foetuses when 










Another biological example displaying the sometimes dramatic different effects of enantiomers is 
the naturally occurring oil from seeds of the caraway plant called carvone.  The (S)-(+)-carvone 




A further illustration of contrasting enantiomer characteristics comes from the agrochemical 
industry, namely (R,R)-paclobutrazol which serves as a fungicide while its enantiomer 4 acts as a 








(S,S)-4   
The synthesis of chiral molecules in optically pure form is not only imperative to the 
pharmaceutical industry but also in the generation of non-linear optical devices,10 the control of 
polymer structure and properties,11 the agrochemical industry,12 flavours, fragrances,13 the study 
of nearly all biochemical processes and the pursuit of understanding molecular recognition.14  
Therefore, chirality has been an important concept in various fields of chemistry and has been 
extensively studied.  Today, the use and demand for optically active molecules is greater than 
ever, hence chiral methodologies in asymmetric synthesis plays a crucial role in science as it can 
provide materials and methods for various applications of chiral compounds.  
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1.2 Routes to Obtain Optically Pure Compounds   
Amongst numerous routes to obtain optically pure or enriched compounds, the basic approaches 
can be divided into the following three classes:  
1.2.1 The “Chiral Pool” 
The chiral pool strategy involves the use of nature’s ‘limited’ catalogue of enantiopure starting 
















 7, Hydroxy acid, (S)-mandelic acid 8, Terpene, (1R,2R,5R)-menthol  
Achiral reagents were utilized to transform chiral starting materials to the desired target molecule 
during the development stages of asymmetric synthesis.  An example making use of the chiral 
pool strategy is the synthesis of the potent β-lactam antibiotic thienamycin 10 which utilizes 
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Several pharmacologically relevant compounds have been synthesized using this approach.  
Despite this fact it suffers severe potential drawbacks which include the cost and availability of 
the stoichiometric amounts of the suitable chiral precursors along with more challenging multi-
step synthetic routes.  For example, the synthesis of taxol, an effective anti-cancer agent, involves 
more than twenty synthetic steps.16  Nevertheless, this method of asymmetric synthesis is still 
frequently utilized. 
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1.2.2 Resolution of Racemates 
Chiral resolution is a process whereby racemic (equimolar) mixtures of the two enantiomers are 
separated.17,18  These methods include enzymatic methods or more commonly diastereomer 
formation in which crystallization or chromatographic techniques are used to separate the 
diastereomers.19,20  A chiral resolving agent (CSA) is used to convert enantiomers into 
diastereoisomers.  A recent example making use of diastereomer formation using a CSA involves 
the synthesis of the drug duloxetine, which has been reported to treat psychiatric disorders.  In a 
part of its synthetic route (S)-mandelic acid (CSA) is added to the racemic mixture 11 resulting in 
the (S)-alcohol complexed to the (S)-mandelic acid to crystallize out of solution.  A basic workup 










The major disadvantage of chiral resolution is that the theoretical yield is limited to 50 % unless 
alternative routes to convert the opposite enantiomer into the desired product is further carried 
out.22  Some enzymatic techniques exist where complete resolution (100 % conversion) of the 
racemate is achieved under conditions where the “other” enantiomer is racemized.23,24  One such 
example is the conversion of racemic hydantoins to a single amino acid enantiomer by means of 
the hydantionase enzyme.23   
1.2.3 Asymmetric Synthesis 
This approach involves the conversion of an achiral starting material into a single enantiomer 
induced by a chiral environment.  At present it is the most powerful and common approach to 




The starting chiral substrate S* is incorporated into the final product and it serves to direct the 
formation of new chiral center/s on the product P*. 
S* P*
R
R = reagents and * denotes chirality  
Auxiliary-Controlled  
A chiral auxiliary A* is deliberately attached to an achiral substrate S.  This serves to direct the 
enantioselective reaction after which the auxiliary is removed or recycled and the 
enantiomerically pure compound is obtained when reacting with the reagent R.  
P*
R








S   
Catalyst-Controlled   
A substiochiometric amount of a chiral catalyst promotes the conversion of an achiral substrate 




Remarkable progress has been made in this field resulting in the vast majority of important 
asymmetric reactions primarily relying on this approach to generate chiral products.17  The 
enormous practical potential of asymmetric catalysis makes it one the most widely explored areas 
of research in recent years.5,17,18   
Asymmetric catalysis is described in more detail in the following section. 
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1.3 Asymmetric Catalysis   
There are three main classes of asymmetric catalysts employed: 
1.3.1 Biocatalysts   
Biocatalysis makes use of enzymatic or microbial methods to effect stereoselective changes to 
unnatural substrates.26  These methods include the use of hydrolases, lipases, lyases etc.  The 
synthetic route of the antibiotic cefalexin has been shortened from ten to six steps using an 
enzymatic procedure.27  There are problems with this methodology as biocatalysts cannot be 
applied to a wide range of asymmetric reactions but recently a steady increase in research output 
in this field has emerged.20,26 
1.3.2 Organocatalyts 
Chiral organocatalysis involves the use of organic molecules as catalysts to promote the 
conversion of achiral substrates into chiral products.26  Due to the limited scope, these catalysts 
had not attracted much attention in asymmetric synthesis.  However, in the past decade there has 
been a substantial increase in the number of studies in this field.26,20  A recent example is the 
alkylation of crotonaldehyde with an organotrifluoroborate salt as the catalyst.28 
1.3.3 Metal-Ligand complexes as catalysts  
These catalysts consist of metal-ligand complexes derived from chiral ligands.  From the 1950’s 
metal-ligand catalysts have had a significant impact on asymmetric catalysis.17  It has been 
extensively studied and provides flexible methods for many types of organic reactions leading to 
some spectacular practical applications.5,17,18   
For the purpose of this project these types of catalysts will be discussed in further detail.   
1.4 Metal-Ligand Complexes Derived From Chiral Ligands 
The advances in asymmetric synthesis utilizing a molecular catalyst that consist of a metallic 
centre and a chiral organic ligand have lifted many of the restrictions on the classical approaches 
to the synthesis of optically pure compounds.  Chiral ligands alter the reactivity and selectivity of 
the metal catalyst such that the transition leading to the product has preference for the formation 
of one enantiomer in an asymmetric reaction.17,25  Figure 1.1 illustrates the general principle 
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behind an asymmetric catalytic reaction promoted by a chiral metal-ligand complex.18  A 
substiochiometric amount of the chiral catalyst 1A combines with the achiral reactant A and 
substrate B to form intermediate 1B.  The chiral environment induced by complex 1B enables the 
asymmetric transformation into the chiral product A-B* [which is either (R) or (S)] via 
intermediate 1C.18 
 
Figure 1.1  Principle of asymmetric catalysis by a metal-ligand complex.18 
Based on this principle numerous metal-ligand complexes have been found to catalyze a range of 
reactions with impressive enantioselectivities.17  Amongst many, a well-known example of an 
industrial application employing asymmetric catalysis using a metal-ligand complex is rhodium 
and (R,R)-1,2-ethanediyl-bis-[(2-methoxyphenyl)-phenylphosphine] or DIPAMP 13.  The 
resulting chiral ligand/metal complex is used in the production of (S)-2-amino-3-(3,4-
dihydroxyphenyl)-propanoic acid 14 commonly known as L-DOPA29, an important anti-
















This project involves the synthesis of novel chiral ligands based on the pentacyclo-undecane 
(PCU) cage compound.  The ligands will be complexed with various metals and the chiral metal-
ligand complexes will be used as catalysts in a typical Diels-Alder reaction.  More details on cage 
compounds and Diels-Alder type reactions follow.  
1.5 Cage Compounds 
Organic chemists have explored the chemistry of polycyclic cage compounds for several 
years.1,30-33  The effect of the unique cage geometry on chemical reactivity and behavior of the 
rest of the molecule has been extensively studied.30-32  Examples of these cage compounds 
include 15-18.  Only trishomocubane 16 is chiral while the remaining cages illustrated below are 
meso-compounds (bearing a stereogenic center with a plane of symmetry).1  
15, Pentacyclo-undecane (PCU) 16, Trishomocubane
17, Basketane 18, Adamantane  
Cage compounds extend their applications into various important fields.  A few examples of these 
applications include:   
Pharmaceuticals 
A well known example of a cage compound employed as a pharmaceutical drug is the anti-
Parkinson’s drug adamantan-1-amine 19.33 
NH2
19  
The cage structure is a useful scaffold to deliver drugs and can also be used to modify and 
improve the pharmacokinetic and pharmacodynamic properties of drugs.30  However, to date not 
many enantiopure cage compounds with promising pharmaceutical characteristics have been 
reported.33 
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Chiral Recognition  
Chiral molecular recognition is an important aspect in various fields of chemistry such as 
asymmetric catalysis,34 enzyme mimics35,36 and enantiomeric separation of racemates.  
Consequently, there is considerable interest in ligands that have potential in monitoring chiral 
host-guest recognition events.37  Marchand et al. incorporated the PCU cage with the chiral 
binaphthol crown ether and this macrocycle 20 showed promising enantioselectivity towards 








Compounds of this type and related analogues form a new class of binaphthol host systems for 
the study of host-guest interactions.   
Since then members of our research group* have been involved in the synthesis of a number of 
chiral PCU ligands.4,39,40  A short summary of the chiral ligands from our group demonstrating 
the application of these compounds in asymmetric catalysis is presented below. 
Asymmetric Catalysis 
PCU cage compounds 21-23 have been incorporated into macrocycles and used as successful 
chiral catalysts in the alkylation of benzaldehyde with diethylzinc and Michael addition 
reactions.4,39,40   
                                                 











a) R = CH2CH3
b) R = CH(CH3)2
c) R = CH2CH(CH3)2





For the purpose of this project, a strategy was developed to synthesize novel PCU derived ligands 
for studying a typical asymmetric Diels-Alder reaction. 
1.6 Scope of Investigation Pertaining to Asymmetric Catalysis  
This project focused on the incorporation of the PCU cage as part of novel chiral ligands.  Since 
this cage has two ‘arms’, it was an attractive option to combine the chemistry of the cage and 
chiral auxiliaries to act as a host to bind to metal ions serving as Lewis acid catalysts (molecules 
or ions capable of coordinating with unshared electron pairs).2  The PCU cage renders the ‘faces’ 
of the ligand inherently diastereotopically non-equivalent, therefore it is expected to play a 
significant role in asymmetric induction when tested in an enantioselective reaction. 
1.7 The Diels-Alder Reaction 
Since the discovery of the Diels-Alder cycloadditon reaction in 192841 there have been more than 
17 000 papers published up to 2002 on the synthetic, mechanistic and theoretical aspects of this 
reaction.42  This reaction plays a prominent role in organic chemistry as it creates two new 
σ−carbon–carbon bonds forming a cyclic molecule in a regio- and stereo-controlled manner.  In 
addition, this reaction can also form carbon-heteroatom and heteroatom-heteroatom bonds.  As a 
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result the Diels-Alder reaction has become an essential tool for constructing simple and complex 
molecules.42  It involves a reaction between a conjugated diene 24 and a dienophile 25 (a 





Figure 1.2  Typical Diels-Alder reaction mechanism. 
Diels-Alder reactions can be carried out under various experimental conditions encompassing a 
variety of different dienes and dienophiles and can take place via intramolecular or intermolecular 
additions.42  An example of an intermolecular addition is the synthesis of the tricyclic compound 
2743 while a combination of intermolecular and intramolecular additions take place in the 


































The discovery that Lewis acids could promote Diels-Alder reactions sparked great interest and 
has become invaluable to synthetic organic chemists.  In 1960 Yates et al.45 reported the first 
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example of a Lewis acid catalyzed non-chiral Diels-Alder reaction of anthracene 29 and maleic 






With Catalyst t1/2 = < 1 min




This breakthrough had important practical ramifications as it demonstrated that the Diels-Alder 
reaction could take place with the presence of an electropositive metal acting as a catalyst.17  In 
1979 Koga et al. reported the first practical example of a catalytic enantioselective Diels-Alder 
reaction of acrolein 32 and cyclopentadiene 33 in the presence of ‘menthoxyaluminum 
dichloride’ as the chiral* catalyst to yield the exo-cycloadduct 34.46   
+
15 mol % Catalyst*





This chiral catalyst was derived from menthol and ethylaluminum dichloride, but its structure 
remains undefined.17  Subsequent studies found Lewis acid catalysts to not only increase the rate 
of the cycloadditon but allow the reaction to proceed under milder conditions; to enable regio- 
and stereoselectivity of the chiral products and permit reactions of unusual dienes and dienophiles 
that would not normally proceed.17,42  Over the years a tremendous amount of Lewis-acid 
catalysts have been reported, including the common Lewis acids such as AlCl3, TiCl4, SnCl4 etc., 
lanthanide complexes, most of which are metal-ligand complexes derived from chiral ligands.  
Asymmetric Diels-Alder reactions involving chiral dienophiles 35-37 form a major component in 
this class of organic reactions and metal-ligand complexes as catalysts for these reactions are 








35 36 37  
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Several of these complexes have been evaluated, examples of a few that have had a profound 
impact on various asymmetric Diels-Alder reactions are illustrated below 38-42. (Please note that 

































The following chapters describe in further detail the novel PCU based chiral ligands investigated 
for this project.  Chapters 2 and 3 briefly discuss PCU-diol and PCU bisimine based ligands 
respectively.  Unfortunately the synthesis of these ligands proved to be difficult and products 
were unstable, therefore catalytic evaluation was not carried out.  Chapter 4 discusses the PCU-
bis (oxazoline) derived ligand in depth since the synthesis of the ligand was successful and its 
potential in a Diels Alder type reaction was evaluated. 
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Chapter 2 
2.1 Chiral Diol Ligands 
From a variety of chiral auxiliaries/ligands, chiral diols have contributed a major part since many 
diols can be obtained from natural sources and are synthons for diamine and diphosphine 
compounds.51  Thus numerous chiral 1,2-, 1,3- and 1,4-diols have been found to be efficient 
chiral ligands.  Some popular chiral diol ligands 43-46 that have displayed excellent 
enantioselectivity in various asymmetric reactions are illustrated below.17,51-55  These ligands are 
versatile as they can be applied to a range of asymmetric reactions.  However, only their 




















(R)-1,1’-Binaphthyl-2,2’-diol 43 commonly known as BINOL is one of the most widely used 
ligands for asymmetric catalysis.5,17,47,56,57  Its use in a range of Diels-Alder reactions have been 
explored by several researchers.47,58  An example is the reaction of an N-alkylacrylamide 47 with 
cyclopentadiene 33 catalyzed by (R)-BINOL 43 and diethylzinc to yield the endo-adduct 48.59   
+
43, Et2Zn












Devine et al. showed that the titanium Lewis acid catalyst derived from (R,R)-hydrobenzoin 44 
and titanium chloride showed promising enantioselectivity in the reaction with the less reactive 
carboxylic ester dienophile 49 and 1,3 diene 50 to furnish the cyclic adduct 51.60 
+
44, TiCl4






The chiral diol (R,R)-2,4-pentanediol 45 has been used to promote the benchmark Diels-Alder 
reaction of 3-acryloyloxazolidin-2-one 52 and cyclopentadiene 33 to yield the endo product 53.61   
+
45, Sc(OTf)2








Several other chiral diol ligand-metal complexes that have been used to catalyze Diels-Alder type 
reactions are reported in literature.51,47,62,63 
2.2 PCU Diol Ligands 
Inspired by the success of the above mentioned ligands in Diels-Alder type reactions it was 




a) R = C6H5
b) R = (C6H5)2
c) R = CH(CH3)2
d) R = CH2CH(CH3)2
 
However, classical synthesis of these compounds 54a-d will produce racemic mixtures.  In order 
to synthesize the above PCU-diol ligands in optical pure form, the meso nature of the PCU cage 
15 had to be altered at some stage as only one enantiomer of the ligands 54a-d was required.  
Naemura et al. reported a procedure to obtain optically pure PCU derivatives by carrying out an 
enzyme-catalyzed reduction on the PCU dione which is the starting material for the above 
ligands.64  As mentioned in chapter 1, enzymatic catalysts are commonly used to influence 
changes on unnatural substrates stereoselectively.26 
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2.3 Synthesis of PCU-Diol Ligands 
For all PCU ligands discussed in this project the overall starting material was the PCU dione 
57.65,66  Coincidently, the synthesis of the PCU dione involves the Diels-Alder reaction of p-
benzoquinone 55 and cyclopentadiene 33 to afford the adduct 56 which then undergoes a 










Scheme 2.1  Synthesis of the PCU dione 57 
Initially it was decided to synthesize the PCU-diol ligand 54a as a racemate for two reasons.  
Firstly the high cost of the enzyme which was required to induce asymmetry onto the cage and 
secondly a literature survey revealed that these ligands were the first example in which lithiation 
techniques were going to be employed to attach aromatic moieties directly to the PCU cage 
(Scheme 2.2).  Once proof of concept was established, one could revert to chiral synthesis of the 
























Rt=Room temperature  
Scheme 2.2  Synthesis of novel PCU-diol ligand 54a 
The synthetic route from the PCU dione 57 to the hydroxyl ketone 60 was carried out from 
established procedures.67-70  The PCU dione 57 was treated with ethylene glycol under Dean-
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Stark conditions to yield the racemic mono-protected ketal 58.  The ketal 58 was then reduced 
using sodium borohydride to the endo-hydroxy acetal 59.  Thereafter the ketal group was 
removed by treatment of 59 with hydrochloric acid to yield the hydroxyl ketone 60.  The 
hydroxyl ketone 60 was then reacted with excess phenyllithium at -78 oC to furnish the novel 
racemic ligand 54a.  The structure of this ligand was confirmed by 1H and 13C NMR spectra and 
the full 2D NMR elucidation was recently published.71  Once the synthetic route to the ligand 
was established, the enzyme horse liver alcohol dehydrogenase (HLADH) was applied to the 
PCU dione 57 to obtain the optically pure hydroxyl ketone 60 as outlined by Naemura et al. 
(Scheme 2.3).64 





57 60  
Scheme 2.3  Enzyme-catalyzed reduction of PCU dione 57 
The PCU dione 57 was incubated at room temperature in a Sorensen phosphate buffer containing 
the HLADH for 72 hours (until which time no staring material was observed on thin layer 
chromatography [TLC] plates).  Analysis of the product obtained from the enzyme-catalyzed 
reduction using high pressure liquid chromatography (HPLC) with a chiral column indicated that 
this product 60 was racemic.  According to literature only one other group72 has been able to 
reproduce the results obtained by Naemura et al.73  It was decided that perhaps the enzyme was 
not fresh enough, therefore the reaction was carried out again with a new batch of HLADH but 
the product 60 was still obtained as a racemate.  It was also decided to carry out the enzyme-
catalyzed reduction on the mono-protected ketal 58 with the fresh batch of HLADH since the 










Scheme 2.4  Attempted enzyme-catalyzed reduction of PCU mono-protected ketal 58 
Tracking this reaction for several days indicated that only starting material was present on TLC 
and no reaction had occurred.  Another approach was required to obtain the hydroxyl ketone 60 in 
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its optically pure form.  The PCU dione 57 was treated with (4S,5S)-4,5-bis([1-hydroxy-1-
methyl]ethyl)-2,2-dimethyl-1,3-dioxolane 61 under Dean-Stark conditions (Scheme 2.5) in the 
hope that this bulky protecting group would form the novel pair of diastereomers 62 that could be 











Scheme 2.5  Protection of the PCU dione 57 
However, separation of these diastereomers 62 proved to be challenging.  Based on the same 
principle another protecting group, (2S,3S)-dimethyl tartrate 63 was employed (Scheme 2.6) but 
unfortunately these novel diastereomers 64 also could not be separated by column 











Scheme 2.6  Protection of PCU dione 57 
Several recrystallization attempts were carried out on the mixtures of 62 and 64 with the 
expectation that one of the diastereomers could possibly precipitate out of solution but none of 
these attempts proved to be successful.   
2.4 Conclusion 
An NMR elucidation of the novel racemic ligand 54a and related compounds was recently 
published.71  The fact that these ligands can be easily obtained via lithiation techniques makes 
further investigation into methods to obtain optically pure PCU precursors a worthwhile study.  A 
possible start could be by applying other types of enzymes on the PCU dione.  A second option is 
to reduce 62 with sodium borohydride and then try to achieve separation of the resulting 
diastereomeric alcohols.  Once symmetry of the PCU cage is broken by reacting one of the ketone 
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groups in a stereo-controlled manner it has the potential to open up an exciting new field of PCU 
ligands that will not be limited to diol type ligands but various other types of chiral ligands.   
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Chapter 3 
3.1 Chiral Salen Ligands 
‘Salen’ is an acronym that refers to a family of bisimine compounds with a N,N’-
bis(salicylidine)ethylenediamine 65 framework.74  The salen ligand 66 was commercialized in 
1994.  It is commonly referred to as ‘Jacobsen’s ligand’ and is well known for its breakthrough in 
asymmetric epoxidation75 reactions although it has shown to be highly effective in numerous 
other asymmetric reactions when complexed to different metals.48,57,75,74,76-78  Following the 
lead of Jacobsen, several other research groups expanded the scope of chiral salen ligands 66-69.  
As a result a wide variety of chiral salen-metal complexes have been developed and serve as 






























Amongst several salen analogue catalysts developed, mainly ligand 66 has been investigated for 
its application in asymmetric Diels-Alder reactions.  Rawal et al. documented the 
enantioselectivity of the Diels-Alder reaction between 1-amino-1,3-butadiene and substituted 
acroleins catalyzed by 66-chromium (III) complexes to be generally greater than 90 %.78,83-85  
They extended their studies to include the trialkylsilyl substituted salen ligand 68 with cobalt (II) 












72 (95 % ee)  
Jurczak et al. investigated the Hetero-Diels-Alder reaction between 1-methoxybuta-1,3-diene 73 
and tert-butyldimethylsilyoxyacetaldehyde 74 catalyzed by a 66-chromium (III) complex  














75 (94 % ee)
TMS = trimethylsilyl  
The potential of ligand 66 with scandium in another Diels-Alder reaction was demonstrated by 
Fukuza et al. between 3-acryloyloxazolidin-2-one 52 and cyclopentadiene 33 to yield endo-53 as 












A literature survey revealed that amongst many salen analogues, ligand 66 has been most often 
investigated for Diels-Alder reactions. 
3.2 PCU Bisimine Ligand 
Due to the success of the salen backbone (such as for 66), it was decided to design the PCU 
bisimine type ligand 80.  This ligand differs from the typical salen framework as it possesses four 
aliphatic hydroxyl groups.  Despite this difference, the presence of the imine functionality which 
is known to be well suited to form complexes with metal ions87 and the close proximity of the 
PCU hydroxyl groups it was anticipated that ligand 80 could perhaps act as a Lewis acid catalyst 
when complexed to a metal ion.  In addition, it would be interesting to determine (if possible) 














Another attractive feature of this ligand was the envisaged final step of the synthesis which 
involves a simple Schiff base condensation2 reaction between the PCU dihydroxy dialdehyde and 
an amino alcohol.74 
3.3 Synthesis of PCU Bisimine Ligand 
The starting material for the synthesis was the PCU dione 57.  The dione 57 underwent a 
Grignard reaction with allylmagnesium bromide to yield the endo-3,5-diallyl-4-oxahexacyclo 
[5.4.1.02,6.03,10.05,9.08,11] dodecane 81 as described from established procedures.39,40,88  This 
PCU diol-diene 81 then underwent ozonolysis followed by a reductive workup using dimethyl 
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sulphide (a mild reducing agent) in attempt to yield the novel PCU dialdehyde 82 as outline in 
Scheme 3.1.  The crude 1H spectrum of this compound 82 indicated the presence of the aldehyde 















Scheme 3.1  Attempted synthesis of PCU dihydroxy dialdehyde 82 
Due to keen interest in PCU bisimine type ligands, further thought was necessary to design the 
initial ligand 80.  It was decided to replace the hydroxyl groups in 82 with an ether bridge since 
the absence of the polar hydroxyl groups would make purification via chromatography easier and 
also previous work on the PCU ether derivatives have been reported.4,40  The endo diol-diene 81 
was dehydrated with a catalytic amount of sulphuric acid in a Dean-Stark apparatus to produce 
the PCU ether diene 83.4,89  Ozonolysis of 83 followed by a reductive workup using dimethyl 
sulphide, afforded the novel PCU ether dialdehyde 84 as illustrated in Scheme 3.2 which was 
purified using column chromatography.  The aldehyde 84 proved to be stable for only 24 hours.  













1) O3, Dry MeOH
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Scheme 3.2  Synthesis of PCU ether dialdehyde 84 
Commercially available (S)-phenylglycine methyl ester 85 was reduced to the corresponding 
amino alcohol 86 using lithium aluminum hydride (Scheme 3.3).90  The amino ester was 






85 86  
Scheme 3.3  Reduction of (S)-phenylglycinol 86 
A Schiff base condensation reaction of 84 with 86 in the presence of molecular sieves afforded 

















Scheme 3.4  Synthesis of PCU ether bisimine ligand 87 
Ligand 87 was stable for an hour, therefore only the 1H and 13C spectra were obtained.  Due to the 
instability of ligand 87 and its precursor 84 it was decided that in situ complexation and testing of 
this ligand would be very difficult. 
3.4 Conclusion 
The full NMR elucidation of the novel PCU ether dialdehyde 84 and other PCU derivatives was 
recently published.91  Due to the difficulty in the purification of the precursor 82, instability of 84 




4.1 Chiral Bis(oxazoline) Ligands 
C2-symmetric bis(oxazoline) ligand-metal complexes have become one of the most versatile and 
commonly used classes of chiral catalysts.50,92-96  Interest in these type of ligands for asymmetric 
catalysis was initiated in 1991 by two successive communications. First by Evans et al. and then 
by Corey et al. for work on asymmetric cyclopropanation of alkenes97 with ligand 89 and Diels-
Alder reactions98 with ligand 90 respectively.  Subsequently, bis(oxazoline) type molecules 
quickly became widely accepted and popular as bidentate ligands due to its facile synthesis and 
remarkable enantioselectivities achieved for the above types of reactions.  A large majority of 
these ligands are derived from readily available chiral amino alcohols.  The enantiocontrolling 
stereocenter lies adjacent to the coordinating nitrogen of the oxazoline ring bringing the active 
metal in close proximity to the stereogenic centers.95,99  Over the years, bis(oxazoline) type 
ligands have developed further by incorporation of two or more oxazoline rings, a range of 











89 (R = t-Bu)























































The diverse range of these ligands when complexed to different metals have found widespread 
applications as successful chiral catalysts in a variety of asymmetric reactions such as, Friedel-
Crafts,101 Heck,102 pinacol coupling,103 epoxidation of olefins,104 allylic oxidation,105 Michael 
addition,106 Hetero-Diels-Alder107 and Mukaiyama aldol94 reactions etc.  However, only their 
application in Diels-Alder reactions will be discussed for the purpose of this study.  Corey et al. 
first described the use of the chiral bis(oxazoline) ligand 90 in the enantioselective Diels-Alder 
reaction between 3-acryloyloxazolidin-2-one 52 and cyclopentadiene 33 catalyzed by the 
complex of 89 with iron (III).  The reaction product 53 was found to be endo-selective with an 
endo:exo ratio of 96:4.98   
+
89, FeCl3













There are four different ways the diene 33 can approach the dienophile 52.  Firstly, the dienophile 
52 can either attack from above the plane of the paper and secondly from below the plane of the 
paper.  (R)-53 is formed via attack of the diene 33 from above the plane of the paper and (S)-53 is 
the result of the diene attacking from below the plane of the paper.  The chiral catalyst is 
supposed to limit the formation of one enantiomer over the other.50  During the reaction of the 
substrates (52 and 33) in the presence of the chiral catalyst 89, the top side of attack is blocked or 
hindered to such an extent that endo-(S)-53 is almost exclusively observed.  Note that in both 
these cases the diene 33 approaches the dienophile 52 with the CH2-group pointing away from the 
carbonyl oxygen of 52.  This is the more kinetically preferred approach and leads to what is 


























The last two possibilities are both the result of the diene 33 attacking the dienophile 52 with the 
CH2-group pointing towards the carbonyl carbon of 52.  Again, two products are possible (i.e 
attack of the diene from either above or below the plane of the paper).  Exo-(S)-53 forms when 
attack is from below the plane of the paper and exo-(R)-53 forms when attack occurs from above 
the plane of the paper.  This approach is the less kinetically preferred and leads to what is called 
the exo-product.2 
There are various other examples of asymmetric Diels-Alder reactions between several different 
dienophiles and dienes that have been tested under different conditions with bis(oxazoline) 
derived catalysts, but the reaction between 3-acryloyloxazolidin-2-one 52 and cyclopentadiene 33 
is the most extensively studied.108-111  This reaction is accepted as the ‘standard’ test for the 
efficiency of bis(oxazoline) derived catalysts since the endo:exo ratio of the product can be easily 
determined by 1H NMR and the enantioselectivity by chiral HPLC analysis.100  Therefore only 
this particular Diels-Alder reaction with a few important examples of bis(oxazoline) derived 
ligands will be discussed here (Table 4.1).   
 29
Complexes of ligands 89-90 have been thoroughly investigated for its role as a catalyst in the 
above mentioned reaction by changing the metal, counterion, solvent, temperature and the effects 
of different additives.  The best metal for ligand 89 appears to be Cu(II) and the best counterions 
are OTf -1 and SbF6-1 (Table 4.1, entries 1-2).  The ideal combination for ligand 90 was reported 
with Zn(SbF6)2 as the metal salt (Table 4.1, entry 3).  
 
Table 4.1 Summary of the best results obtained for the reaction between 3-
acryloyloxazolidin-2-one 52 and cyclopentadiene 33 catalyzed by ligands 89-94 with CH2Cl2 
as the solvent.  









1 (S)-89 Cu(OTf)2 -78 86 98:2 1 >98 (S) 112-115 
2 (S)-89 Cu(SbF6)2 -78 >95 96:4 4 >98 (S) 112,116 
3 (S)-90 Zn(SbF6)2a -78 >90 98:2 8 92 (R) 112,116 
4 (S)-91 Sc(OTf)3 -78 63 98:2 2 82 (S) 117 
5 (R)-91 La(OTf)3 -20 >99 69:31 16 >99 (R) 118 
6 (R)-92 Mg(OTf)2 -50 >99 89:11 16 94 (R) 119 
7 (R)-93 Ni(ClO4)2b -40 96 97:3 14 >99 (S) 120 
8 (R)-94 Cu(SbF6)2 -84 66 92:8 c 98 (R) 121 
aAddition of molecular sieves, bThe hexahydrate was salt used, cNot reported. 
 
Studies on ligands 89-90 with respect to its coordination geometry and electronic properties aided 
by single crystal X-ray data and NMR analysis have also been carried out to understand their 
function in asymmetric reactions.122,123  An interesting analysis of the above reaction occurred 
with (R)-90 and Mg(ClO4)2.
50,122  When the counterion is perchlorate the product of the reaction 
is (S)-53, but if two equivalents of water are added to the reaction the product obtained is (R)-53.  
If the counterion is changed to triflate the reaction product is (R)-53 and no change occurs to the 
enantioselectivity of the reaction product even if water is added.  This result was rationalized by 
establishing that water acts as an auxiliary ligand that expands the coordination number from four 
(tetrahedral) to six (octahedral) when the counterion is perchlorate.  The ligand-metal complex 
with the more nucleophilic triflate counterion already has an octahedral geometry and therefore 
does not change upon the addition of water.50  This change in coordination is supported by NMR 
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spectroscopy experiments; the position of the water ligands was determined by replacing water 
with ethylene glycol.122,124,125 
The best results for ligand type 91 were obtained with lanthanide complexes (Table 4.1, entry 4-
5).  Desimoni et al.118 investigated the catalysts derived from 92 with different metal salts.  The 
optimum results emerged with Mg(OTf)2 (Table 4.1, entry 6).  The cationic aqua complexes 
prepared from ligand 93 with various metal perchlorates were studied by Kanemasa et al.120 with 
Ni(II) appearing to yield excellent enantioselectivity (Table 4.1, entry 7).  Morena et al.121 
synthesized ligand 94 and tested the Cu(II) complexes of this ligand in several reactions including 
the above Diels Alder reaction (Table 4.1, entry 8).  A trend displayed by all the catalysts 
mentioned above and in related literature is that an increase in enantiomeric excess results from a 
decrease in temperature since better kinetic resolution is obtained at lower temperatures.  These 
low temperatures however, result in longer reaction times which sometimes becomes impractical.   
This literature review prompted the design of a novel PCU based bis(oxazoline) type ligand.   
4.2 PCU Bis(oxazoline) Ligand 
Motivated by the success of the bis(oxazoline) type ligands 89-99 and its application in Diels-










Since the PCU cage has two ‘arms’ it seemed promising to combine the chemistry of the cage 
with that of two oxazoline moieties to act as a chiral ligand for asymmetric catalysis.  The PCU 
cage renders the ‘faces’ of the ligand inherent diastereotropically non-equivalent therefore it was 
expected to play a significant role in asymmetric induction when coupled with oxazoline 
moieties.  It also offers a central ether type oxygen which could potentially participate in the 
binding of the metal, thus leading to a tridentate complex.  Bis(oxazoline) catalysts complexes 
with this arrangement have not been pursued to any large extent for examples see references 
120,126,127. 
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4.3 Synthesis of PCU Bis(oxazoline) Ligand 
Synthesis of the novel PCU bis (4-phenyloxazoline) ligand 100 followed the classical route 
involving the reaction of a diacid derivative (in this case the PCU diacid) with an amino alcohol 
to give the bis-amide intermediate that is converted to the bis(oxazoline).50,95  The PCU dione 57 
was converted to the 3,5-diallyl-4-oxahexacyclo[5.4.1.02,6.03,10.05,9.08,11]dodecane 83 as described 
in chapter 3.40,88  Ozonolysis of 83 followed by an oxidative workup using formic acid and 
hydrogen peroxide afforded the PCU diacid 101 which was carried out from an established 

















Scheme 4.1  Synthesis of PCU diacid 101 
To avoid competing reactions due to the hydroxyl group on the amino alcohol 86 (Scheme 3.3) 
it was decided to protect the alcohol by using tertiary butyl dimethyl silyl chloride (TBDSi) to 
give (S)-tert-butyldimethylsilyl-2-amino-3-phenylpronoate 102.128  This protecting group is 
known to be selective towards hydroxyl groups in the presence of a primary amine.  A N,N-
dicyclohexylcarbodiimide (DDC) promoted condensation of the PCU diacid 101 with 102 
afforded the novel protected PCU bis-amide 103 which was purified using column 
chromatography as adapted from literature.129  The novel PCU bis-amino alcohol 104 was 
obtained by deprotection of 103 with tetra-N-butylammonium fluoride (TBAF) and purification 
was again achieved using column chromatography based on the related report.128  Cyclization 
was achieved by the chlorination of 104 using thionyl chloride to give the PCU bis-chloride 105 
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as shown in Scheme 4.2.  Note that the source of chirality is (S)-102 with the stereogenic center 
being unchanged in the remainder of the synthesis.  The elucidation of these ligands with the use 
































Scheme 4.2  Synthesis of PCU bis-chloride 105 
The PCU bis-chloride 105 was not isolated due to instability.  The crude 1H NMR spectrum for 
105 displayed a downfield shift of the -CH2Cl (5.02 ppm) in comparison with -CH2OH (3.73 
ppm) in 104, which confirmed the synthesis of 105.  Hence, without further purification the PCU 
bis-chloride 105 was treated with aqueous sodium hydroxide50,120 to yield the novel ligand PCU 
bis(4-phenyloxazoline) 100 as outlined in Scheme 4.3 The novel ligand 100 was isolated by 



















Scheme 4.3  Synthesis of the novel PCU bis(4-phenyloxazoline) 100 
The full characterization of the novel compounds 100, 103 and 104 will be discussed in section 
4.5.2 
4.4 Results  
The efficiency of ligand 100 was tested with the benchmark enantioselective Diels-Alder reaction 
between 3-acryloyloxazolidin-2-one 52 and cyclopentadiene 33.  Various alkali earth and 
transition metals that are known to complex to bis(oxazoline) derived ligands were screened for 
the in situ formation of the catalyst complex with the ligand (S,S)-100.  The enantioselectivities 
of the various metals are reported in Table 4.2.  The complexation procedure involved the 
addition of an equimolar amount of the metal salt to a solution of the ligand in dichloromethane 
and the details are reported in the experimental section.97   
+











Table 4.2 Results obtained for the reaction between 3-acryloyloxazolidin-2-one 52 and 
cyclopentadiene 33 catalyzed by ligand (S,S)-100 complexed to various metal salts with 
CH2Cl2 as the solvent at room temperature.   








1 Blank 240 80 96:4 0 - 
2 Ca(ClO4)2 45 77 84:16 33 R 
3 Cu(ClO4)2 30 71 86:14 25 R 
4 Zn(ClO4)2 15  75 88:12 40 R 
5 Ni(ClO4)2 120 60 83:17 25 S 
6 Mg(ClO4)2 15  85 90:10 72 S 
7 Ba(ClO4)2 150 17 80:20 0 - 
8 Al(ClO4)2 20 86 83:17 0 - 
9 Co(ClO4)2 45 86 86:14 28 S 
10 Fe(ClO4)2 15  62 86:14 30 S 
11 Mn(ClO4)2 60  78 89:11 36 S 
12 Cu(OTf)2 75 55 81:19 7 S 
13 Sc(OTf)2 15 62 85:15 5 S 
14 Ca(ClO4)2.4H2O 45 80 86:14 43 R 
15 Zn(ClO4)2.6H2O 15 71 88:12 56 R 
16 Ni(ClO4)2.6H2O 30 73 88:11 20 S 
17 Mg(ClO4)2.6H2O 30 82 90:10 70
 S 
18 Co(ClO4)2.6H2O 15 82 83:17 15 S 
19 Mn(ClO4)2.6H2O 45 75 86:14 28 S 
a Determined by 1H NMR, b Determined by HPLC (Chiralpak IB). 
 
Since anhydrous magnesium perchlorate gave the highest enantiomeric excess it was decided to 





Table 4.3 Effect of different solvents on the reaction between 3-acryloyloxazolidin-2-one 52 
and cyclopentadiene 33 catalyzed by ligand (S,S)-100 complexed to Mg(ClO4)2 at room 
temperature.   
Solvent Time (min) Yield (%) Endo:exo Endo ee (%) 
DCM 15  85 90:10 72 (S) 
THF 150 87 89:11 2 (S) 
CH3CN 240 80 92:8 14 (S) 
 
Once it was established that dichloromethane (DCM) was the best solvent it was decided to 
optimize the counterion of the metal-ligand complex. 
Table 4.4 Effect of different counterion on reaction between 3-acryloyloxazolidin-2-one 52 
and cyclopentadiene 33 catalyzed by ligand (S,S)-100 and Mg with CH2Cl2 as the solvent at 
room temperature.   
Metal salt Time (min) Yield (%) Endo:exo Endo ee (%) 
Mg(ClO4)2 15  85 90:10 72 (S) 
MgBr2 240 60 90:10 2 (S) 
MgCl2 150 48 92:8 8 (S) 
Mg(OTf)2 120 73 91:9 17 (S) 
Mg(SbF6)2 30 95 92:8 23 (S) 
 
Thereafter the effect of catalytic loading, addition of additives and temperature on this reaction, 
was investigated.  
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Table 4.5 Effect of different catalytic loading, additives and temperature on reaction 
between 3-acryloyloxazolidin-2-one 52 and cyclopentadiene 33 catalyzed by ligand (S,S)-100 









Endo:exoa Endo ee 
(%)b 
1 1 rt 60 80 87:13 25 (S) 
2 5 rt 45 79 89:11 30 (S) 
3 10c rt 15 86 90:10 71 (S)
4 10 rt 10 87 90:10 72 (S) 
5 10d rt 10 86 90:10 72 (S)
6 10 0 30 84 90:10 74 (S)
7 10 -40 e - 98:2 81 (S)
rt = Room temperature, a Determined by 1H NMR, b Determined by HPLC (Chiralpak IB), c 4 Å Molecular 
sieves added, d slow addition of cyclopentadiene over 1hr, e Reaction was too slow and stopped after 24 hrs, 
it did not go to completion. 
In the next section the observed results and efforts to explain the enantioselectivity will be 
discussed. 
4.5 Discussion 
The first part of this discussion will cover the evaluation of the ligand 100 in the Diels-Alder 
reaction between 3-acryloyloxazolidin-2-one 52 and cyclopentadiene 33 and the second part will 
cover the elucidation of the novel compounds 103, 104 and 100.   
4.5.1 Evaluation of the novel ligand 100 in the Diels-Alder reaction 
From the various metals salts evaluated, anhydrous Mg(ClO4)2 emerged as the best Lewis acid in 
terms of enantioselectivity (Table 4.2, entry 6) of the endo-cycloadduct product 53.  Other 
bis(oxazoline) magnesium complexes previously reported also display reasonable catalytic 
activity in this Diels-Alder reaction.120,124,130  Although the Mg(ClO4)2.6H2O demonstrated a 
comparable enantiotiomeric excess to its anhydrous counterpart (Table 4.2, entries 6 and 7), this 
result was not pursued as the reaction mixture upon complexation of the hexahydrate metal salt 
was not homogenous.   
Substitution of the solvent dichloromethane (DCM) with tetrahydrofuran (THF) or acetonitrile 
(CH3CN) led to lower yields and enantioselectivities (Table 4.3).  Different magnesium salts were 
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investigated to determine the effect of the different counterion on the catalyst in the reaction 
(Table 4.4).  These results indicated that the enantiomeric excess improved with increasing Lewis 
acidity of the metal [Mg(OTf)2< Mg(SbF6)2< Mg(ClO4)2].   
Once the optimum solvent and counterion was found, different catalytic loadings were 
investigated and 10 mol % yielded the best result (Table 4.5, entries 1-2 and 4).  Also the addition 
of molecular sieves to ensure strictly anhydrous conditions did not significantly affect the 
enantiomeric excess or yield of the reaction (Table 4.5, entry 3).  In order to evaluate the reaction 
temperature-enantioselectivity profile, experiments at room temperature, 0 oC and -40 oC were 
carried out (Table 4.5, entries 5-7).  As expected for this reaction, the enantiomeric excess 
increased with decreasing temperature.98,112,120  Experiments at lower temperatures were 
impossible due to extremely low reaction rates, therefore the reaction at -40 oC was the best result 
obtained with an enantiomeric excess of 81 % (Table 4.5, entry 7). 
It was important to note that the blank reaction (Table 4.2, entry 1) proceeded (i.e. without any 
catalyst) much slower.  In order to investigate to what extent the enantioselectivity was 
influenced by the non-catalyzed (racemic products form) reaction, the experiment was performed 
with slow addition of cyclopentadiene (Table 4.1, entry 5).  From the data, it was clear that the 
enantioselectivity was not influenced by the concurrent non-catalyzed racemic reaction.     
From the metals screened (Table 4.2, entries 2-4) namely, calcium, zinc and copper products 
resulted in excess of the (R)-enantiomer whilst the other metals gave rise to excess of the (S)-
enantiomer.  According to literature bis(oxazoline) ligands are known to sometimes reverse the 
chirality of 53 when zinc or copper are used.100,112,113,116,119  There are no other reports in 
literature on bis(oxazoline) calcium complexes tested on Diels-Alder type reactions, therefore a 
comparison to the calcium result could not be made.   
The inversion of chirality on the products when zinc or copper are used was attributed to the 
different transition states experienced by the complex as a result of changing the metal cation or 
substituents on the ligand.114  Corey et al.130 observed, when magnesium complexes of (R)-90 
(R=Ph) were tested for the reaction, that the predominant product was the (S)-configuration.  
They proposed a tetrahedral magnesium-bis(oxazoline) dienophile complex to account for the 
observed asymmetric induction.  Evans et al.113 proposed a square planar coordination for the 
copper complex of (R)-89 (R=t-Bu) in which the product was the (R)-configuration for the same 
Diels-Alder reaction.  An interesting observation occurred when both Evan’s and Corey’s ligands 
with the (R)-configuration were complexed to magnesium.  When the counterion is perchlorate 
the product of the reaction is (S)-53, but if two equivalents of water is added to the reaction the 
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product obtained is (R)-53.125  This stereochemical outcome was explained by Desimoni et al. by 
establishing that water acts as an auxiliary ligand which will expand the coordination number 
from four (tetrahedral) to six (octahedral) when the counterion is perchlorate.50,124,131   
Since our best result was from Mg(ClO4)2 it was decided to do a theoretical investigation to 
determine if the tetrahedral complex form proposed in literature is applicable in the reaction 
investigated by us.  Optimizations of the two possible conformations of the magnesium complex 
of ligand 100 with the substrate 52 were performed using Density Functional Theory (DFT) 
calculations.  The first complex A has the unsaturated bond of the dienophile 52 facing upwards 
while the second structure (complex B) has it facing downwards.  
 
Figure 4.1 Optimized structures of the ligand-Mg-dienophile complexes [B3LYP/6-
31+G(d)].†  
The geometry of both complexes was penta-coordinate.  The calculations revealed the distance 
between the magnesium ion and imine nitrogens to be 2.18 Å and 2.11 Å.  The distance between 
the magnesium ion and carbonyl oxygen of the dienophile was 2.01 Å.  The ether oxygen on the 
PCU moiety also participated in binding to the magnesium ion since the calculated metal to 
oxygen distance was 2.21 Å.  It was then sensible to propose that the reacting catalyst complex 
between ligand 100 and dienophile 52 was a penta-coordinated system (Figure 4.1 ) and behaves 
similarly to the octahedral complex suggested by Desimoni et al.  This could possible explain the 
observation of no inversion occurring on the chirality of the reaction product.  This implied that 
ligand 100 is one of very few tridentate N,O,N-bis(oxazoline) type ligands reported.120,132,133   
                                                 
† The Cartesian coordinates of these structures are available on a CD that accompanies this thesis. 
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In addition, the calculated energies of these possible complex structures show that complex A is 
more energetically favoured than complex B by 5 kcal mol-1.  Upon inspection of the low energy 
complex structure it was quite clear that the Re face of the unsaturated bond of the dienophile 52 
is much less hindered than the Si face (Figure 4.1).  This will lead to the (S)-endo product 53.  
This theoretical result was consistent with the experimentally observed absolute configuration 
and enantiomeric purity of the (S)-endo product 53 determined by chiral HPLC analysis.   
 
Further more, inspection of the HOMO‡ of the computational complex structure also revealed that 
the dienophile (oxazolidinone 52) experienced a high level of delocalization (Figure 4.2 ).   
 
 
Figure 4.2  Illustration of the calculated HOMO orbitals of the ligand-Mg-dienophile 
complex.   
This delocalization will explain the rigidity of the dienophile which prevents rotation around the 
C-1’-C-2’ bond as indicated in Figure 4.3. 
                                                 
‡ The cube file of the calculated complex HOMO is available on a CD that accompanies this 













Figure 4.3 Extraction of dienophile 52 from the complexed structure. 
Oxazolidinone in form 52a will yield the correct product for pro-S attack whilst 52b will give the 
opposite enantiomer.  Note that cyclopentadiene attacks the alkene with the CH2 group furthest 
away from the carbonyl oxygen as explained earlier in this chapter.   
Finally, the NMR elucidation of the novel chiral ligands will be discussed below.  
4.5.2 Elucidation of the novel compounds 103, 104 and 100.  
The following results was recently published.91  For the purpose of this discussion, a basic 
knowledge of NMR techniques (including 2D experiments) and terms is assumed.  If additional 
reading is required, the reader is referred to numerous excellent NMR textbooks.134-136 
Two dimensional NMR proved to be a powerful technique in overcoming the difficulties 
associated with the elucidation of PCU cage compounds when only one dimensional NMR data is 
utilized.  Since a chiral substituent was attached to the PCU derivatives 103, 104 and 100, the 
cage therefore displayed C1 symmetry which resulted in all its atoms being non-equivalent.  Note 
that the left half of the PCU skeleton is the mirror image of the right half, with the result that the 
chiral side arms induce a diastereomeric character to the cage skeleton.  Due to overlapping in the 
1H spectra, identification of the non-equivalent protons was challenging.  However, the 13C 
spectra gave rise to clear splitting of the carbon atoms (C-1 to C-11) and (C1’ to C-8’) on the 













































The splitting of all side chain carbons (C-1 to C-8’) is unprecedented compared to analogous 
PCU derivatives previously reported.137-141  The nature of this effect was investigated and is 
herein discussed.  From the 1H spectrum of 103, the characteristic methylene protons (H-4) 
register as doublets at 1.65 ppm (H-4a) and 1.98 ppm (H-4b) with a coupling constant of 10.5 Hz 
which corresponds to analogous PCU ligands.137-141  Due to major overlapping of protons, only 
the coupling constant of H-4 could be calculated.  Also from the 1H spectrum, protons H-3’ and 
H-4’ at 5.21 ppm and 4.05 ppm were assigned respectively by integration of the signals.128,142  In 
addition the silyl protons was assigned based on integration, 0.0 ppm (H-10’ = 12 H’s) and 0.9 
ppm (H-11’ = 18 H’s).  Recording the 13C spectra in attach proton test (APT) mode assisted in 
distinguishing the quaternary and methylene carbons from the methine and methyl carbons.  
Based on the HSQC spectrum of 103 the corresponding carbons to H-4’ and H-4 were identified.  
By way of elimination the methylene signal at 3.0 ppm was assigned to C-1’ (later confirmed by 
HMBC correlation to the cage) and its HSQC correlation to the doublet at 2.56 ppm led to the 
assignment of H-1’.  H-1’ also displayed a COSY and NOESY interaction with the overlapping 
cage methine signals at 2.87 ppm.  The quaternary carbons were assigned as follows:  C-9’ was 
assigned to 18.2 ppm due its correlation to the silyl protons in the HMBC spectrum; C-5’ was 
assigned to 140 ppm based on its correlations to H-3’ and H-4’ and C-2’ to 169 ppm which is 
characteristic of a carbonyl carbon.  C-2’ also has HMBC correlations to H-3’, H-1’ and the 
aromatic protons (7.36-7.52 ppm).  Through elimination the quaternary carbon at 94.1 ppm was 
assigned to the diastereomeric C-8 and C-11 carbons.  All the cage carbon signals display 
splitting as a result of the diastereomeric effect (induced by the chiral side arm).  The nature of 
this effect is confirmed due to the absence of any splitting of the non-chiral (non-diastereomeric) 
methylene signal of H-4.  In addition, high temperature NMR experiments of 103 at 60 oC, 120 
oC and 150 oC revealed that the cage carbon signals of C-1/7, C-9/10 and C-8/11 remained split 
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throughout the temperature ramp.  This confirmed the diastereomeric effect experienced by these 
carbon atoms.   
This is the first report where splitting of all the cage carbon atoms was observed.  Previous 
reports of similar PCU diasteromeric ligands observed splitting only of the cage atoms closest to 
the source of chirality.137-141  The proton signal appearing at 2.56 ppm displayed a HMBC 
correlation to a cage carbon signal at 44.1 ppm and a COSY and NOESY correlation to H-4; 
therefore it could either be assigned to H-2/6 or H-3/5.  However this signal (44.1 ppm) also 
shows HMBC with H-1’, thus eliminating H-2/6.  Therefore the signal at 44.1 ppm was assigned 
to H-3/5.  Signals at 58.0 ppm share HMBC correlations to H-4, H-1’, H-3/5 and the overlapping 
cage protons.  The possibility of this signal being C-1/7 was ruled out as it cannot correlate to H-
4; these carbon signals were therefore assigned to C-9/10.  The remaining cage carbon signals at 
47.0 ppm and 41.4 ppm were assigned to C-1/7 and C-2/6 respectively based on the HMBC and 
NOESY interactions.   
In view of the above stated assignments the overlapping cage methine protons at 2.87 ppm results 
from H1/7, H2/6 and H9/10.  Interestingly, the aromatic protons (7.36-7.52 ppm) show NOESY 
interactions with H-1’, H1/7, H2/6, H9/10 and H-3/5.  The silyl protons H-10’ and H-11’ display 
NOESY interactions with H-1’, H1/7, H2/6 and H9/10.  This observation suggests a conformation 
of 103 in which one of the ‘arms’ is perhaps positioned in front and the other at the back of the 
cage moiety.  From the high temperature experiments, the split carbon signals on the side arm (C-
1’to C-8’) at room temperature gradually became a single peak as the temperature was increased 
indicating these carbon atoms experienced splitting due to a conformational effect.  When the 
hetero-atoms on the side arms are positioned in close proximity to the cage it induces a through 
space deshielding effect resulting in non-equivalence of atoms on the cage and that of the ‘arm’ 
similar to a previous report of a related chiral PCU ligand.139,141   
The IR spectrum of 103 displayed a sharp N-H absorption at 3312 cm-1, methyl absorptions at 
2949 cm-1 and 2929 cm-1 and the absorption at 1646 cm-1 confirmed the presence of the amide 
bond.  The mass spectrum of 103 exhibited the correct molecular ion peak at m/z 743.4146 (M + 
H+).  The same methodology was used to elucidate the structure of 104.  All the carbon signals of 




































A possible explanation could be the absence of the bulky t-butyl dimethyl silyl group in 104 
hence the conformational effect in which one of the ‘arms’ is closer to a different part of the cage 
moiety is less pronounced.   
From the IR spectrum the presence of the alcohol group was confirmed by the broad band at 3292 
cm-1 and as with 103 the presence of the amide bond absorption was recorded at 1641 cm-1.  
Presence of the expected molecular ion peak of m/z 515.2418 (M + H+) in the mass spectrum 
confirmed the formation of compound 104. 
The elucidation of the PCU bis(4-phenyloxazoline) ligand 100 followed a similar approach as 
presented above.  The 1H spectrum of 100 differs from its precursors in that all the cage protons 




































From the 13C spectrum, the absence of the carbonyl carbon signal at 170 ppm and the presence of 
the characteristic imine carbon signal at 165 ppm was indicative that cyclization was achieved.  
Also, C-3’ displays a distinct downfield shift as a result of the adjacent imine bond.  HMBC 
correlations of C-2’ with protons H-3’ and H-4’ confirms the formation of the oxazoline ring.  
The aromatic protons (7.21-7.38 ppm) show a NOESY interaction with H-2/6.  Similar to 103 
this observation indicates the different conformations of 100 in which the ‘arms’ exists as 
different conformations with respect to the cage moiety.   
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A weak but observable COSY correlation between H-3’ and H-1’ is observed which is unusual as 
these protons are more than three bonds apart.  This was attributed to a rare long range ‘through 
space’ coupling which has been reported in systems with proton correlations that are five-six 
bonds apart.143-145  These couplings are known to occur when an intervening atom is sp2 
hybridized146 or when an oxygen147 or sulphur148 atom is involved.  In this case an oxygen atom 
and sp2 nitrogen are present between protons H-3’ and H-1’ which appears to result in this long 
range interaction.   
The IR spectrum of 100 displays the characteristic imine absorption band at 1663 cm-1 and an 
aromatic ether absorption band at 1217 cm-1.  Also, as expected the disappearance of the amide 
bond absorptions was observed.  The mass spectrum of 100 displays the correct molecular ion 
peak at m/z 479.2350 (M + H+).  The detailed NMR assignments for 103, 104 and 100 are 
presented in Table 4.6 
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Table 4.6 NMR data for PCU derivatives 103, 104 and 100a. 
Derivative 103 Derivative 104 Derivative 100 
Atom no. 1H ppmb 13C ppm 1H ppmb 13C ppm 1H ppmb 13C ppm 
1/7 2.87 48.83/47.82 2.73 48.63/48.01 2.82 48.67/48.58
2/6 2.87 41.50/41.44 2.73 41.54/41.39 2.64 41.86/41.84
3/5 2.56 44.28/44.19 2.45 44.12/44.00 2.41 44.64/44.61
4a 1.65 43.35 1.55 43.48 1.51 43.55 
4b 1.98 43.35 1.90 43.48 1.90 43.55 
8/11 - 94.21/94.16 - 94.14 - 93.71/93.69
9/10 2.87 59.11/58.06 2.73 59.05/58.40 2.75 59.26/59.16
1’ 3.06 39.91/39.89 2.82 39.49/39.47 2.98 32.11/32.96
2’ - 169.2/169.1 - 170.1 - 165.9/165.8
3’ 5.21 54.64/54.60 5.02 55.23/55.17 5.18 69.66/69.61
4’ 4.05 66.60/66.11 3.73 65.90 4.61/4.08 74.76/74.69
5’ - 140.36/140.30 - 139.33/139.32 - 142.3 
6’ 7.52 126.92/126.91 7.43 126.6 7.34 126.5 
7’ 7.43 128.52/128.32 7.29 128.6 7.28 128.8 
8’ 7.36 127.24/127.27 7.23 127.6 7.24 126.5 
9’ - 18.26     
10’ 0.984 -5.600     
11’ 0.003 25.83     
a Solvent CDCl3,  b. 400 MHz for 1H and 100 MHz for 13C. 
4.6 Conclusion  
The novel PCU bis(4-phenyloxazoline) ligand 100 was synthesized and tested on the asymmetric 
Diels-Alder reaction between 3-acryloyloxazolidin-2-one 52 and cyclopentadiene 33.  The 
anhydrous magnesium perchlorate complex emerged as the best catalyst providing the endo-
cycloadduct product 53 of the above mentioned reaction in 81 % enantiomeric excess with an 
endo:exo ratio of 98:2.  From the molecular modeling of this magnesium complex with substrate 
52, the more energetically favoured conformation was established which had the Re-face of the 
dienophile in a less hindered position.  Diels-Alder cycloaddition of cyclopentadiene to the Re-
face leads to a product consistent with the experimentally observed endo product 53.  A penta-
coordinated complex system is observed in the computational complex.  The calculated bond 
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length revealed that the ether oxygen of the PCU moiety acts as at donor atom to the magnesium 
ion in the complex.  The computational model also suggests that further modifications on the 
PCU skeleton will not influence asymmetric induction and therefore further study will focus on 
the derivatisation on the R-group of the oxazoline moiety and testing of ligand 100 and its 
analogues on additional asymmetric catalytic reactions.  
The NMR elucidation of the novel ligand (S)-pentacyclo-undecane bis-(4-phenyloxazoline) 100 
and two of its precursors 103-104 was successfully achieved.  2D NMR techniques were required 
to identify the NMR signals for the PCU derivatives which display C1 symmetry with all the cage 
atoms being non-equivalent.  The 13C spectra of these derivatives gave rise to clear splitting of the 
non-equivalent carbons with exception to C-9’, C-10’, C-11’ in 103, C-8/11, C-2’, C-4’, C-6’, C-
7’, C-8’ in 104 and C-6’, C-7’, C-8’ in 100.  NOESY correlations of derivatives indicated 
conformational differences with respect to the side arms.  The hetero-atoms on the side arm 
induced a through space deshielding effect resulting in non-equivalence of atoms on the cage 
skeleton and that of the ‘arm’.  Even though the cage carbons become diastereomeric with respect 
to the chiral side arms, the same level of non-equivalence by related chiral cage ligands have not 




Incorporation of the PCU cage as part of a novel chiral ligand was investigated, this included 
PCU diol 54a, PCU bisimine 87 and PCU bis(oxazoline) 100.  The PCU diol ligand was 
synthesized, however various methods (enzymatic methods, diastereomer formation and 
recrystallization) that were utilized to obtain the compound enantiomerically pure proved to be 
unsuccessful.  This hindered further investigation into this type of ligand.  The PCU bisimine 
ligand was synthesized, but due to its instability it was not further pursued.  Synthesis of the PCU 
bis(oxazoline) ligand 100 was successful and it was complexed to various metal salts and tested 
on the benchmark asymmetric Diels-Alder reaction between 3-acryloyloxazolidin-2-one 52 and 
cyclopentadiene 33.  The anhydrous magnesium perchlorate complex emerged as the best catalyst 
providing the endo-cycloadduct product 53 in 81 % enantiomeric excess at -40 oC.  Optimizations 
of the possible conformations of the magnesium complex of ligand 100 with the substrate 52 
were performed using Density Functional Theory (DFT) calculations.  The more energetically 
favoured complex conformation was established.  The Re-face of the dienophile is less hindered 
which should produce a product consistent with the experimentally observed product 16.  Based 
on the calculated bond lengths from the computational model binding of the ether oxygen on the 
PCU moiety to magnesium was observed.  This implied that ligand 100 is one of very few 
tridentate N,O,N-bis(oxazoline) type ligands reported so far.  In addition, the complete NMR 
elucidation of the novel PCU diol 54a, PCU ether dialdehyde 84, PCU bis-amide 103, PCU bis-
amino alcohol 104 and (S)-pentacyclo-undecane bis(4-phenyloxazoline) 100 was successfully 
achieved. 
 48
Chapter 6  
6.1 Experimental 
General 
All solvents were distilled from the appropriate desiccant.  Infrared spectra were obtained on a 
Perkin Elmer Spectrum 100 instrument with an Attenuated Total Reflectance (ATR) attachment.  
Optical rotations were carried out on a Perkin Elmer 341 polarimeter.  All melting points are 
uncorrected. Column chromatography was carried out using silica gel 60.  Electron spray mass 
spectra were carried out on a Waters LCT Premier Time of Flight (TOF) mass spectrometer.  
HPLC analysis was carried out with a Shimadzu Prominence fitted with a LC-2AD pump, SIL-
20A auto sampler and SPD-M2OA diode array detector.  The type of column and conditions are 
described within the appropriate experiment below.  NMR spectra were recorded on a Bruker 
AVANCE ΙΙΙ 400 MHz instrument.   
Parameters for the NMR experiments ran in CDCl3 were as follows:  The 1H NMR spectrum was 
recorded at 400.222 MHz (spectral width, 8223.685 Hz; acquisition time, 1.992 s; pulse width, 
9μs; scans, 16; relaxation delay, 1.0 s). The 13C NMR spectrum was recorded at 100.635 MHz 
(spectral width, 24038.461 Hz; acquisition time, 1.363 s; pulse width, 13.801 μs; scans, 2400; 
relaxation delay, 2.00 s).   
The 2D experimental data parameters were as follows: 90o pulse width, 9 μs for all spectra; 
spectral width for 1 H, 822.68 103, 104, 100; spectral width for 13C, 24038.46 for 103, 104, 100; 
number of data points per spectrum, 2048, (COSY) for 103, 104, 100, 2048, (NOESY) for 103, 
104, 100, 4096, (HMBC) for 103, 104, 100, 1024 (HSQC) for 103, 104, 100 ; number of time-
incremented spectra, 128 (COSY) for 103, 104, 100, 256, (NOESY) for 103, 104, 100, 128, 
(HMBC) for 103, 104, 100, 256 (HSQC) for 103, 104, 100; relaxation delay, 1.38 s (COSY) for 
104 and 100, 1.39 s (COSY) for 103, 1.98 s (NOESY) for 104 and 100, 1.96 s (NOESY) for 103, 
1.31s, 1.25 s, 1.30 s (HMBC) for 103, 104, 100 respectively, 1.45 s, 1.43 s, 1.45 s, (HSQC) for 
103, 104, 100 respectively; spectra acquired in phase-sensitive mode, 103, 104, 100 (NOESY and 
HSQC); spectra acquired in absolute value mode, 103, 104, 100  (COSY and HMBC); gradients 
used for 103, 104, 100 (COSY, HSQC and HMBC). 
Synthesis of Pentacyclo-[5.4.0.02,6.03,10.05.,9]-undecane-8,11-dione-mono-ethylene ketal 58.69 
A mixture of the dione 5765 (183 g, 1.05 mol), ethylene glycol (89.9 g, 1.45 mol), p-
toluenesulfonic acid (6.11 g, 32.1mmol) in dry benzene (800 ml) was gently refluxed with stirring 
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in a Dean-Stark trap for four days thereby ensuring azeotropical removal of water.  The reaction 
mixture was left to cool and poured slowly into an ice-cold saturated aqueous sodium carbonate 
solution.  The aqueous mixture was extracted with 4 x 250 ml portions of CH2Cl2.  The combined 
organic extracts were dried over anhydrous Na2SO4.  The mixture was filtered and the solvent 
evaporated in vacuo.  The resulting brown residue was recrystallised from hexane to give 58 as a 
white solid (135g, 74 %).  Melting point = 73.0-74.0 oC.  1H NMR (CDCl3): δ = 1.55 (d), 1.8 
7(d), 2.47 (m), 2.6 (m), 2.81 (m), 2.91 (m).  13C NMR (CDCl3): δ = 36.3 (d), 38.7 (t), 41.3 (d), 
41.4 (d), 42.3 (d), 42.8 (d), 45.8 (d), 50.7 (d), 53.0 (d), 64.5 (t), 65.7 (t), 113.9 (s) and 215.3 (s). 
Synthesis of 11-Hydroxypentacyclo-[5.4.0.02,6.03,10.05.,9]-undecane-8-one--ethylene ketal 59.69 
The mono-ketal 58 (10.0 g, 45.9 mmol) was dissolved in methanol (100 ml) and placed in an ice-
bath to cool.  A solution of sodium borohydride (3.50 g in 50 ml methanol) was added, while 
stirring over 15 minutes.  The mixture was left to stir for two hours in an ice-bath and an 
additional two hours at ambient temperature.  A small amount (2 ml) of the mixture was 
withdrawn from the flask and extracted with CH2Cl2 to confirm complete reduction of the keto 
functional group using IR spectroscopy.  The solvent was removed in vacuo, and the residue 
extracted using 100 ml of CH2Cl2.  Compound 59 was obtained (7.80 g, 78 %) as a clear oil.  1H 
NMR (CDCl3): δ= 1.16 (d), 1.65 (d), 2.34 (m), 2.55(m), 2.72 (m).  13C NMR (CDCl3): δ = 35.0 
(d), 38.8 (d), 39.0 (d), 39.2 (d), 39.9 (d), 43.6 (d), 44.6 (d), 46.7 (d), 47.2 (d), 72.35 (d), 62.9 (t), 
65.5 (t) and 115.8 (s). 
Synthesis of 11-Hydroxypentacyclo-[5.4.0.02,6.03,10.05.,9]-undecane-8-one.69 
The hydroxy-ketal 59 (10.0 g, 45.4 mmol) was dissolved in methanol (100 ml) and placed in an 
ice-bath to cool.  Concentrated hydrochloric acid (100 ml) was added and the solution was stirred 
for 1 hour.  The ice bath was removed and the mixture stirred overnight.  The solvent was 
removed in vacuo, and the residue extracted using 100 ml of CH2Cl2.  A white solid 60 was 
obtained (8.5 g, 85 %).  Melting point = 254-255 oC.  1H NMR (CDCl3): δ = 1.51(d), 1.87 (d), 
2.55 (m), 2.83(m), 4.05 (m), 4.60 (m) and 5.72 (s).  13C NMR (CDCl3): δ = 36.8 (d), 38.4 (t), 40.5 
(d), 41.5 (d), 43.2 (d), 44.7 (d), 45.2 (d), 45.6 (d), 71.8 (d), 81.4 (d) and 119.2 (s). 
Synthesis of the novel Ligand 54a. 
A solution of bromobenzene in dry THF (5 mol equivalents relative to 60) was cooled under 
nitrogen atmosphere to -78 oC using a dry-ice-acetone bath.  Butyllithium solution (15 % in 
hexane, 1.2 mole equivalents relative to bromobenzene) was added and the solution stirred for 10 
minutes.  A solution of the hydroxy-ketal 60 (1 mol equivalent) in dry THF was added and the 
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solution stirred at -78 oC for 1 hour and then at room temperature overnight.  The reaction was 
quenched by the dropwise addition of water.  The white precipitated product was filtered off and 
the solvent was removed in vacuo.  The unprecipitated product was isolated using column 
chromatography (EtOAc/Hexane = 50:50, Rf = 0.5) to yield the ligand as a white solid (1.05g, 73 
%).  Melting point = 126-130 °C. IR νmax: 3068(m), 2967(m), 1484(m), 1104(s), 1070(s), 700(vs) 
cm-1., HRMS calculated for C17H18O2 (M + H+) 254.1344, found 254.1345.  1H NMR (CDCl3) δ = 
0.99 (H-4a), 1.51 (H-4s), 1.79 (H-5), 2.35 (H-3), 2.55 (H-9), 2.56 (H-2), 2.58 (H-6), 2.59 (H-10), 
2.86 (H-1), 3.12 (H-7), and 7.33 (H-2’).  13C NMR δ = 34.11 (C-4), 38.90 (C-1), 39.01 (C-20), 
41.50 (C-7), 41.52 (C-6), 44.30 (C-3), 46.10 (C-10), 46.69 (C-5), 71.92 (C-11), 79.40 (C-8), 
81.31 (C-9), 125.45 (C-2’), 127.19 (C-4’), 128.38 (C-3’), 146.29 (C-1’). 
Enzyme catalyzed reduction on PCU dione 57.64 
To one liter of Sorensen buffer (pH 7.0) a mixture of 0.05 g of NAD+, 0.11g HLADH and 2.0 g of 
PCU dione dissolved in 5 ml of ethanol was added.  The reaction vessel was sealed and left to stir 
for 72 hours until which time no more starting material was present on TLC plate (EtOH/Hexane 
= 50:50).  The reaction mixture was extracted with 4 x 250 ml portions of CH2Cl2.  The combined 
organic phases were dried with anhydrous Na2SO4 and the solvent was removed in vacuo. The 
resulting residue was purified by column chromatography (EtOAc/Hexane = 50:50, Rf = 0.3) to 
afford product 60 (4.5 g, 83 %) as white solid.  The enantiomeric excess determined by HPLC 
with a Daicel IB column (hexane-i-PrOH = 90/10) flow rate = 1 L/min, Racemic mixture with 
retention times 17.0 min and 19.3min.  The HPLC chromatograph appears in Appendix A. 
Enzyme catalyzed reduction on PCU mono-protected ketal 58. 
To 500 ml of Sorensen buffer (pH 7.0) a mixture of 0.01g of NAD+, 0.05g HLADH and 0.53 g of 
PCU 57 was dissolved in 1 ml of ethanol was added.  The reaction vessel was sealed and left to 
stir until which time no more starting material was present on the TLC plate.  This reaction did 
not proceed even after several days only starting material was observed on the TLC plate. 
Protection of PCU dione 57 with 61. 
A mixture of the dione 57 (1.00 g, 57.5 mmol), (4S,5S)-4,5-bis([1-hydroxy-1-methyl]ethyl)-2,2-
dimethyl-1,3-dioxolane 61 (3.22 g, 6.99 mmol), p-toluenesulfonic acid (1.00 g, 5.80 mmol) in dry 
benzene (100 ml) was gently refluxed with stirring in a Dean and Stark trap for two days.  The 
reaction mixture was left to cool to room temperature and then poured slowly into an ice-cold 
saturated aqueous sodium carbonate solution.  The aqueous mixture was extracted with 100 ml of 
CH2Cl2.  The combined organic phases were dried with anhydrous Na2SO4 and the solvent was 
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removed in vacuo. The resulting residue was attempted to be purified by column chromatography 
using (EtOH/Hexane = 50:50) but the desired product was not obtained.   
Protection of PCU dione 57 with 63. 
A mixture of the dione 57 (1.00 g, 57.5 mmol), (2S,3S)-dimethyl D-tartrate 63 (1.50 g, 6.99 
mmol), p-toluenesulfonic acid (1.00 g, 5.80 mmol in dry benzene (100 ml) was gently refluxed 
with stirring in a Dean and Stark trap for two days.  The reaction mixture was left to cool to room 
temperature and then poured slowly into an ice-cold saturated aqueous sodium carbonate 
solution.  The aqueous mixture was extracted with CH2Cl2 (100 ml).  The combined organic 
phases were dried with anhydrous Na2SO4 and the solvent was removed in vacuo. The resulting 
residue was attempted to be purified by column chromatography using (EtOH/Hexane = 50:50) 
but the desired product was not obtained.   
Synthesis of exo-8-exo-11-Diallylpentacyclo[5.4.0.02,6.03,10.05,9]undecane-endo-8-endo-11-diol 
81.39,40 
A solution of dione 57 (3.0 g, 17.3 mmol) in dry THF (200 ml) was added dropwise over 1.5 
hours to a stirred mixture of freshly prepared allylmagnesium bromide under nitrogen at 0 oC.  
After the addition had been completed, the external ice-water bath was removed, and the reaction 
mixture was allowed to warm gradually to ambient temperature while stirring under nitrogen 
during 24 hours. The reaction was quenched by the addition of saturated aqueous NH4Cl (until 
pH was 6~7), the layers were separated, and the aqueous layer was extracted with EtOAc (2 x 
100 ml).  The combined organic extracts were dried over anhydrous Na2SO4 and filtered, and the 
filtrate was concentrated in vacuo.  The residue resulting residue was purified by column 
chromatography (Hexane/EtOAc = 80:20, Rf = 0.35) to afford 81 (3.54 g, 78 %) as viscous 
colourless liquid.  1H NMR (CDCl3): δ =  1.05 (AB, JAB = 10.8 Hz, 1 H), 1.49 (AB, JAB = 10.8 Hz, 
1 H), 1.97-2.24 (m, 6 H), 2.30-2.61 (m, 6 H), 5.01 (dd, J = 8.0 & 2.6 Hz, 2 H), 5.04 (dd, J = 16.85 
and 2.6 Hz, 2 H), 5.90 (m, 2 H), 6.52 (br s, 2 H); 13C NMR (CDCl3): δC 33.9 (t), 40.0 (d), 42.8 
(d), 44.0 (d), 44.1 (t), 49.1 (d), 77.2 (s), 117.5 (t), 133.8 (d). 
Synthesis of PCU dihydroxy dialdehyde 82.39 
A solution of the diene 7 (5.0 g, 20.3 mmol) in dry methanol (150 ml) was cooled to -78°C via 
application of an external dry ice–acetone bath and then was purged with nitrogen for 20 minutes. 
Ozone was bubbled into the mixture until a blue-purple color persisted, thereby indicating the 
presence of excess ozone and completion of reaction.  Excess ozone was flushed from the 
reaction vessel with a stream of nitrogen.  The reaction mixture was then transferred to a round 
bottom flask and (CH3)2S (6.4 ml, 83.2 mmol) was added and stirred for 12 hours at ambient 
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temperature.  The solvents were evapourated in vacuo and the residue was extracted with CH2Cl2 
(150 ml).  The combined organic extracts were dried over anhydrous Na2SO4 and the solvents 
were removed in vacuo.  The resulting residue was attempted to be purified by column 
chromatography (Hexane/EtOAc = 70:30) to afford the PCU dialdehyde 82 but unfortunately it 
was not obtained.   
Synthesis of 3,5-Diallyl-4-oxahexacyclo[5.4.1.02,6.03,10.05,9.08,11]dodecane 83.40 
A solution of 81 (3.5 g, 0.014 mol) and p-toluenesulphonic acid (0.5 g, 2.9 mmol) in benzene 
(~250 ml) was refluxed using a Dean-Stark apparatus. After every 12 hours, additional p-
toluenesulphonic acid (0.25 g) was added.  When TLC indicated the absence of 81 (72 hours), the 
reaction mixture was allowed to cool to ambient temperature and washed sequentially with 10 % 
aqueous NaHCO3 (100 ml), water (100 ml) and brine (100 ml). The organic layer was dried over 
anhydrous Na2SO4 and concentrated in vacuo.  The residue was purified via column 
chromatography (Hexane/EtOAc = 80:20, Rf = 0.7, ) to yield 83 as a brown oil, (2.50 g, 70 %). 
1H NMR (CDCl3): δ = 1.46 (AB, JAB = 10.2 Hz, 1 H), 1.82 (AB, JAB = 10.2 Hz, 1 H), 2.35 (br s, 2 
H), 2.45-2.65 (m, 10 H), 5.01 (dd, J = 9.8 & 2.2 Hz, 2 H), 5.07 (dd, J = 15.4 and 1.4 Hz, 2 H), 
5.78 (m, 2 H); 13C NMR (CDCl3): δ =37.5 (t), 41.7 (d), 43.3 (t), 44.5 (d), 47.8 (d), 58.6 (d), 95.1 
(s), 116.8 (t), 134.4 (d).  
Synthesis of the novel PCU ether dialdehyde 84.40 
A solution of the diene 83 (5.0 g, 20.3 mmol) in dry methanol (150 ml) was cooled to -78 °C via 
application of an external dry ice–acetone bath and then was purged with nitrogen for 20 minutes. 
Ozone was bubbled into the mixture until a blue-purple color persisted, thereby indicating the 
presence of excess ozone and completion of reaction.  Excess ozone was flushed from the 
reaction vessel with a stream of nitrogen.  The reaction mixture was then transferred to a round 
bottom flask and (CH3)2S (6.4 ml, 83.2 mmol) was added and stirred for 12 hours at ambient 
temperature.  The solvents were evapourated in vacuo and the residue was extracted with CH2Cl2 
(150 ml).  The combined organic extracts were dried over anhydrous Na2SO4 and the solvents 
were removed in vacuo.  The resulting residue was purified by column chromatography 
(Hexane/EtOAc = 70:30, Rf = 0.6) to afford the PCU dialdehyde 84 (0.49 g, 49 %) as a yellow 
oil. IR νmax: 2958 cm -1 (s) 1719 cm -1 (vs), 1075 (s) and 527 cm -1 (w).  HRMS calculated for 
C15H16O3 (M + H+) 245.1133, found 244.1099.  The NMR elucidation of this compound was 
recently published.91  1H NMR (CDCl3) δ = 1.59 (H-4a), 1.93 (H-4s), 2.50 (H-3/5), 2.64 (H-
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9/10), 2.68 (H-1/7), 2.71 (H-2/6), 2.85 (H-1’) and 9.77 (H-2’).  13C NMR δ = 48.57 (C-1/7), 41.62 
(C-2/6), 44.16 (C-3/5), 43.45 (C-4), 92.77 (C-8/11), 59.21 (C9/10), 45.99 (C-1’), 200.5 (C-2’).   
Reduction of (S)-phenylglycinol 86.90 
(S) Phenylglycine methyl ester (1.0 g, 4.9 mmol) was added to a stirred solution of lithium 
aluminum hydride (0.4 g, 9.8 mmol) in dry THF (150 ml) at ambient temperature.  Thereafter the 
solution was refluxed for 1.5 hr.  The reaction mixture was then removed from heat and allowed 
to cool after which an equal volume of diethyl ether was added.  The reaction was quenched with 
saturated aqueous Na2SO4 solution.  It was filtered and the solvent removed in vacuo to yield pure 
amino alcohol as yellow crystals (0.6 g, 88 %).  1H NMR (CDCl3) δ = 2.80 (O-H, H-4), 3.5-.7 
(2H, m, H-3), 4.0 (1H, m, H-2), 7.2-7.4 (1H, dd, H-3’) and 7.50 (5H, m, aromatic H-5 to H-10).  
13C NMR δ = 58.9 (C-2), 70.0 (C-3), 126-128 (aromatic, C-6 to C-10), 142.0 (C-5). 
Synthesis of PCU diimine 87. 
PCU dialdehyde 84 (0.05 g, 0.20 mmol) was dissolved in 5 ml dry CHCl3 and 86 (0.10 g, 0.40 
mmol) was added along with 4A molecular sieves.  The reaction mixture was left to stand without 
stirring for 1.5 hours.  The reaction mixture was filtered and the solvent removed in vacuo to 
afford the PCU diimine 87 (0.14 g, 100 %) as a brown oil.  1H NMR (CDCl3) δ = 1.01 (AB, JAB = 
10 Hz, 1H), 1.52 (AB, JAB = 10 Hz, 1H), 2.13–2.62 (m), 3.3-3.8(m); 4.15 (H-3’), 4.05 (H-4’) and 
7.2-7.4 (aromatic).  13C NMR δ = 48.1 (C-1/7), 41.5 (C-2/6), 44.1 (C-3/5), 43.5 (C-4), 94.1 (C-
8/11), 59.1 (C9/10), 38.4 (C-1’), 162.5 (C-2’), 58.5 (C-3’), 68.0 (C-4’), 140.1 (C-5’), 126-130 (C-
6’, C-7’, C-8’), 18.1 (C-9’), -4.2 (C-10’) and 26.0 (C-11’). 
Synthesis of 5,5-Dicarboxymethyl-4-oxahexacyclo[5.4.1.02,6.05,10.05,9.08,11]dodecane 101.40 
A solution of the diene 83 (5.0 g, 20.3 mmol) in dry methanol (150 ml) was cooled to -78 °C via 
application of an external dry ice–acetone bath and then was purged with nitrogen for 20 minutes. 
Ozone was bubbled into the mixture until a blue-purple color persisted, thereby indicating the 
presence of excess ozone and completion of the reaction.  Excess ozone was flushed from the 
reaction vessel with a stream of nitrogen, and the reaction mixture was concentrated in vacuo to 
yield the ozonide. Hydrogen peroxide (50 ml, 30 %) was added dropwise to a stirred, ice bath 
cooled mixture of the ozonide and formic acid (50 ml, 80 %). The resulting mixture was stirred at 
ambient temperature for 1 hour and then gently refluxed for 12 hours.  The reaction mixture was 
allowed to cool gradually to ambient temperature during which time the product precipitated out 
of solution.  Pure 101 (4.7 g, 82 %) was thereby obtained as a white microcrystalline solid.  
Melting point = 175-175.5 OC, 1H NMR (DMSO) δ = 1.45 (AB, JAB=10 Hz, 1H),1.83 (AB, 
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JAB=10 Hz, 1H), 2.36–2.80 (m, 12H), 12.15(br s, 2H); 13C NMR δ = 37.94 (t), 41.27 (d), 42.81 
(t), 44.04 (d), 47.91(d), 58.55 (d), 92.56 (s) and 171.40 (s). 
Synthesis of (S)-tert-Butyldimethylsilyl 2-amino-3-phenylpronoate 102.128,142 
(S)-Phenylglycine methyl ester (1.0 g, 4.9 mmol) was added to a stirred solution of lithium 
aluminum hydride (0.4 g, 9.8 mmol) in dry THF (150 ml) at ambient temperature.  Thereafter the 
solution was refluxed for 1.5 hr.  The reaction mixture was then removed from heat and allowed 
to cool after which an equal volume of diethyl ether was added.  The reaction was quenched with 
saturated aqueous Na2SO4 solution.  It was filtered and the solvent removed in vacuo to yield pure 
amino alcohol as yellow crystals (0.6g, 88 %).  To a solution of the amino alcohol (3.0 g, 21.7 
mmol) in dry CH2Cl2 (150 ml) were added at room temperature Et3N (6.3 ml, 44.5 mmol) and 
DMAP (0.5 g, 4.09 mmol). The solution was cooled to 0 °C and TBDMSiCl (3.4 g, 27.7 mmol) 
in CH2Cl2 (20 ml) was added. The solution was stirred for further 48 h at room temperature and 
then H2O (30 ml) was added. The layers were separated and the aqueous layer was extracted with 
CH2Cl2 (150 ml).  The combined organic phases were dried with anhydrous Na2SO4 and the 
solvent was removed in vacuo. The resulting residue was purified by column chromatography 
(CH2Cl2/MeOH = 95:5) to afford product 102 (4.5 g, 83 %) as a yellow oil. 1H NMR (CDCl3) δ = 
0.04 (6H, s), 0.91 (9H, s), 1.85 (NH, br s), 3.50 (1H, dd CH2O), 3.72 (1H, dd, CH2O), 4.07 
(1H,dd, CHPh), 7.40-7.23 (5H, m); 13C NMR (CDCl3) δ =-5.41 (CH3), 18.3 (CH3), 
25.9(C(CH3)3), 57.6 (CHPh), 69.5 (CH2O), 126.9, 127.2, 128.2, 142.6 (aromatic).   
Synthesis of the novel PCU bis -amide 103. 
To a stirred solution of 101 (2.0 g, 7.25 mmol) in dry CH2Cl2 (150 ml), hydroxybenzotriazole (2.0 
g, 14.6 mmol) and DCC (3.0 g, 14.6 mmol) were added respectively.  This mixture was allowed 
to stir for 15 minutes until a clear homogenous solution was obtained.  Thereafter a mixture of 
102 (4.5 g, 18.0 mmol) and Et3N (4.0 ml, 28.9 mmol) in dry CH2Cl2 (50 ml) was added and the 
resulting mixture was stirred at ambient temperature for a further 12 hours.  The reaction mixture 
was then filtered and H2O added to the filtrate.  The layers were separated and the aqueous layer 
was extracted with CH2Cl2.  The combined organic phases were dried over anhydrous Na2SO4 
and the solvent was removed in vacuo. The resulting residue was purified by column 
chromatography (Hexane/EtOAc = 50:50, Rf = 0.7) to afford compound 103 (4.8 g, 90 %) as a 
yellow solid.  [α]20D-11.35 (c = 1 g/100 ml, CH2Cl2).  IR νmax:  3312 cm -1 (s), 1646 cm -1 (vs), 
1112 cm -1 (vs) and 776 cm -1  (vs). Melting point = 126-130 oC.  HRMS calculated for 
C43H62N2O5Si2 (M + H+) 743.4231, found 743.4146.  The NMR elucidation of this compound was 
recently published91 and appears in Table 4.6 
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Synthesis of the novel PCU bis-amino alcohol 104. 
The PCU bis-amide 103 (5.5 g, 7.41 mmol) was dissolved in dry THF (200 ml) and tetra-N-
butylammonium fluoride (29.6 ml, 1 M in THF) was added. The mixture was stirred for 48 hours 
at ambient temperature. Brine was added and the layers were separated.  The aqueous layer was 
extracted with EtOAc (150 ml). The combined organic layers were dried over anhydrous Na2SO4 
and the solvents were removed in vacuo.  The resulting residue was purified by column 
chromatography (EtOAc/MeOH = 95:5, Rf = 0.5) to afford the deprotected alcohol 104 (3.0 g, 76 
%) as a pale yellow solid.  [α]20D+32.45 (c = 1 g/100 ml, CH2Cl2).  IR νmax:  3288 cm -1 (br), 1641 
cm -1 (vs), 1039 cm -1 (s) and 706 (vs).  Melting point 50-52 oC.  HRMS calculated for 
C31H34N2O5 (M + H+) 515.2501, found 515.2418.  The NMR elucidation of this compound was 
recently published91 and appears in Table 4.6  
Synthesis of the novel PCU bis(4-phenyloxazoline) 100.120 
To a stirred solution of 104 (1.0 g, 1.88 mmol) in dry CH2Cl2 (100 ml), SOCl2 (2.7 ml, 37.5 
mmol) was added.  The solution was stirred at ambient temperature for 3 hours.  The resulting 
mixture was poured into H2O and extracted with CH2Cl2.  The combined organic extracts were 
dried over Na2SO4 and the solvent removed in vacuo to yield a brown residue of the PCU bis-
chloride 105 (100% EtOAc, Rf = 0.8) which was used without further purification.  The residue 
was treated with NaOH (1 g in 20 ml H2O) in a MeOH (50 ml)/CH2Cl2 (30 ml) solution at 
ambient temperature for 12 hours.  The organic solvents were evapourated in vacuo and the 
residue was extracted with CH2Cl2.  The combined organic extracts were dried over anhydrous 
Na2SO4 and the solvents were removed in vacuo.  The resulting residue was purified by column 
chromatography (100 % EtOAc, Rf = 0.6) to afford the PCU bis (4-phenyloxazoline) 100 (0.72 g, 
80 %) as a yellow oil.  [α]20D-57.24[c = 0.85 g/100ml, (CH3)2CHOH].  IR νmax: 2964 cm -1 (w) 
1663 cm -1 (s), 984 cm -1 (s) and 700 cm -1 (vs).  HRMS calculated for C31H30N2O3 (M + H+) 
479.2290, found 479.2350.  The NMR elucidation of this compound was recently published91 
and appears in Table 4.6 NMR data for PCU derivatives 103, 104 and 100a.. 
Synthesis of 3-(2-Propenoyl)-2-oxazolidinone 52.112 
To a solution of freshly vacuum distilled acrylic acid (0.98 ml, 14.3 mmol) in EtOAc (80 ml) at 0 
oC was added Et3N (2.5 ml, 14.3 mmol), followed by acyolyl chloride (1.16 ml, 14.3 ml) via a 
syringe.  An immediate white precipitate formed and the reaction mixture was stirred at ambient 
temperature for 30 minutes.  The reaction mixture was then filtered through paper, and the filter 
cake washed with EtOAc.  The resultant cloudy filtrate was concentrated in vacuo.  The residue 
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was dissolved in dry hexane (100 ml), then filtered and concentrated in vacuo again.  The 
anhydride was dissolved in 50 ml dry THF and immediately used in the following step.  To a 
suspension of 2-oxazolidinone (1.0 g, 11.5 mmol) and LiCl (0.61 g, 14.3 mmol) in dry THF (100 
ml), Et3N (2.5 ml, 14.3 mmol) was added via  a syringe followed by the anhydride solution via a 
cannula, followed by a 20 ml wash.  The resulting slurry was stirred at ambient temperature for 
12 hours.  The solvent was removed in vacuo.  To the residue 1N HCl (50 ml) solution was added 
and extracted with CH2Cl2 (50 ml).  The combined organic extracts were washed with saturated 
aqueous NaHCO3 followed by brine and dried over anhydrous Na2SO4 and the solvent was 
removed in vacuo.  The resulting yellow oil was purified by column chromatography 
(Hexane/EtOAc = 50:50, Rf = 0.55) to afford the pure 3-(2-Propenoyl)-2-oxazolidinone 52 (1.3 g, 
81 %) as white crystalline solid.  Melting point = 80-81 oC.  1H NMR (CDCl3) δ = 4.0-4.2 (2H, 
m, H-4), 4.4-4.5 (2H, m, H-5), 5.91 (1H, dd, H-3’), 6.56 (1H, dd, H-3’) and 7.50 (1H, dd, H-2’).  
13C NMR δ = 42.63 (C-4), 62.17 (C-5), 126.99 (C-2’), 131.82 (C-3’), 153.41 (C-2) and 165.08 
(C-1’). 
General Procedure for the Diels-Alder Reactions catalyzed by the PCU bis (4-
phenyloxazoline) complexes.120 
Preparation of the anhydrous Magnesium (II) complex. 
A mixture of PCU bis(4-phenyloxazoline) 100 ligand (17 mg, 0.04 mmol), anhydrous MgBr2 (6.5 
mg, 0.04 mmol), and anhydrous AgClO4 (14.7 mg, 0.08 mmol) in dry CH2Cl2 (5 ml) was stirred 
under dry nitrogen at ambient temperature for 6 h, during which time a gray precipitate of silver 
bromide appeared. The resulting suspension was used without filtration for the Diels-Alder 
reactions as follows: 3-acryloyl-2-oxazolidinone 52 (50 mg, 0.4 mmol) and freshly distilled 
cyclopentadiene 33 (0.3 ml, 4.0 mmol) were added to this suspension.  The reaction was 
performed at room temperature and monitored by TLC. After the completion of reaction, 
saturated aqueous ammonium chloride (20 ml) was added and the mixture was extracted with 
CH2Cl2 (20 ml).  The combined organic extracts were dried over anhydrous Na2SO4 and the 
solvents were removed in vacuo.  The resulting residue was purified by flash column 
chromatography (Hexane/EtOAc = 50:50, Rf = 0.7) to give a mixture of endo and exo isomers of 
cycloadduct 53 (60 mg, 85 %).  The endo:exo ratio was evaluated on the basis of the 1H NMR 
spectrum and the enantiomeric excess determined by HPLC with a Daicel Chiralpak IB column 
(Hexane/i-PrOH = 95/5) flow rate = 1 L/min, t(R)  22.0 min, t(S)  20.2 min.  Other anhydrous 
PCU bis(4-phenyloxazoline) complexes were prepared according to a similar procedure by using 
anhydrous metal halides such as NiBr2, CaBr2, MnBr2, FeCl2, CoBr2, CuCl2, and ZnI2 .  
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Preparation of the hydrated complexes. 
The hexahydrated complexes of the ligand 100 with Mg, Mn, Co, Ni, Zn and Ca (II) perchlorates 
was carried out according to a similar procedure as stated above without adding the silver 
perchlorate. Isolation and analysis of the product was exactly the same as outlined above. 
3-(Bicyclo[2.2.1]hept-5-en-2-ylcarbonyl)-2-oxazolidinone 53.112,120 
Colorless solid; enantiomeric purity was estimated on the basis of HPLC using a chiral column as 
described above and the endo:exo ratio was evaluated on the basis of the 1H NMR spectrum.  
Melting point = 86-87 OC.  1H NMR (CDCl3) δ = 1.3-1.7 (3H, m, H-3 and one of H-7), 1.9-2.1 
(1H, m, the other of H-7), 2.94 (1H, m, H-1 or H-4), 3.31 (1H, m, H-4 or H-1), 3.8-4.1(3H, m, H-
2 and H-4’), 4.40 (2H, t, H-5’), 5.88 (1H, dd, H-5), and 6.25 (1H, dd, H-6); 13C NMR (CDCl3) δ 
= 29.56 (C-3), 42.89, 42.95, 43.21, 46.39 (C-1, C-2, C-4, and C-4’), 50.18 (C-7), 61.97 (C-5’), 
131.63, 138.11 (C-5 and C-6), 153.41 (C-2’), and 174.75 (CO).  The HPLC chromatograph 
appears in Appendix A. 
Computational details 
Complexes A and B were optimized using GAUSSIAN 03149 utilizing density functional theory 
(DFT) in the gas phase at the B3LYP level of theory with the 6-31+(G)d basis set.  Diffuse 
functions are typically used for a more accurate description where lone pair electrons are 
involved, while polarization functions remove some limitations of the basis set by expansion of 
the virtual space.  Solvation effects were not considered in order to simplify the model.  Cartesian 
coordinates of the optimized structures are available as on a CD that accompanies this thesis.  
Various variations of the starting geometry were explored, but it was quite clear that the rigid 
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